SubHero Banner
Text

Orencia® (abatacept) – New indication

June 30, 2017 – The FDA approved Bristol-Myers Squibb’s Orencia (abatacept) injection for the treatment of adult patients with active psoriatic arthritis (PsA).

Download PDF